查詢結果分析
來源資料
相關文獻
- 胰島素製劑的演進發展與臨床應用
- Clinical Implication of Transient Hyperglycemia in Childhood
- 手術麻醉期間的血糖控制
- 重症病患的血糖控制
- 第二型糖尿病病程中造成胰臟β細胞功能受損的病因及治療
- 第二型糖尿病患者的血漿鉻濃度測量
- 運用慢性照護模式於長期血糖控制不佳個案之加護經驗
- Effect of Low-carbohydrate Diet on F-18 FDG PET/CT in a Patient with Prominent Skeletal and Cardiac Muscles FDG Uptake after Insulin Administration
- Effect of Low-carbohydrate Diet on F-18 FDG PET/CT in a Patient with Prominent Skeletal and Cardiac Muscles FDG Uptake after Insulin Administration
- ACARBOSE使用於口服降糖藥物失效之第2型糖尿病患者--臨床評估
頁籤選單縮合
題名 | 胰島素製劑的演進發展與臨床應用=The Development and Clinical Use of Insulin |
---|---|
作者 | 鄭淑妃; 周美惠; 林明芳; Cheng, Sue-fei; Chou, Mei-huei; Lin, Ming-fang; |
期刊 | 榮總護理 |
出版日期 | 20010300 |
卷期 | 18:1 2001.03[民90.03] |
頁次 | 頁8-14 |
分類號 | 418.271 |
語文 | chi |
關鍵詞 | 糖尿病; 胰島素; 高血糖; Diabetes; Insulin; Hyperglycemia; |
中文摘要 | 自從1921年Banting醫師發現胰島素以來,胰島素不僅解救無數第1型糖尿患的生命,也成第2型糖尿患改善血糖控制的最後法寶,而胰島素製劑更是經歷多次演進,就來源,由原始的動物胰臟萃取物到高純度胰島素製劑,由人類胰島素至胰島素類似物;就作用時間而言,由短效而中長效,再由超速效型到目前甫上市的insulin glargine長效型;製劑種類型態感來感多,固然有利於糖尿病之控制,然對胰島素較生疏的臨床工作者則是一大挑戰,充份瞭解胰島素製劑,恪守臨床應用準則,是協助病患邁向優質血糖控制的不二法門。 |
英文摘要 | Dr. Banting discovered insulin in 1921, not only rescuing the number of Type 1 diabet4es, but also improving Type 2 patients' blood sugar control. Insulin preparations have evolved dramatically over the past 60 years, characterized by species source-from the primitive animal pancreas to the highly purified insulin preaarations, and from the human insulin to human insulin analogue; and by time course of activity-from short-acting analog (just available in the year of 2000). The more kinds of insulin preparations, the more benefits for diabetes control are. Nevertheless more challenge for inexperienced clinical guidelines are necessary to lead patients into high quality glycemic control. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。